Diabetic Macular Edema Responds Best to Frequent Ranibizumab

In the Ranibizumab for Edema of the Macula in Diabetes Study, patients treated aggressively with ranibizumab during year 3 had reduced foveal thickness and improved best-corrected visual acuity.
Medscape Medical News

Full Story →